跳至主要内容
临床试验/NCT03668392
NCT03668392终止2 期

Asparaginase Activity Monitoring (AAM) in Adult Patients With Acute Lymphoblastic Leukemia (ALL)

Gruppo Italiano Malattie EMatologiche dell'Adulto7 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2020年6月25日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
终止
入组人数
7
试验地点
7
主要终点
Number of patients with active serum Asparaginase

研究概览

简要总结

In order to understand how pharmacokinetics and immunological inactivation affect the therapeutic efficacy of Asparaginase (ASP), it is of help and advised in the frame of clinical font-line protocols to monitor the enzymatic activity by measuring the serum ASP levels in the days following the administration of the drug.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed written informed consent according to ICH/EU/GCP and national local laws
  • Age 18 - 65 years
  • Diagnosis of untreated Ph- ALL entering treatment including PEG-ASP in induction and consolidation
  • ECOG performance status 0-2, unless a performance of 3 is unequivocally caused by the disease itself and not by pre-existing comorbidity, and is considered and/or documented to be reversible following the application of antileukemic therapy and appropriate supportive measures

排除标准

  • Diagnosis of Burkitt's leukemia
  • Down's syndrome
  • Adults with Ph+ ALL
  • Pre-existing, uncontrolled pathology such as heart failure (congestive/ischemic, acute myocardial infarction within the past 3 months, untreatable arrhythmias, NYHA classes III and IV)
  • Severe liver disease with serum bilirubin >3 mg/dL and/or ALT >3 x upper normal limit (unless attributable to ALL)
  • Kidney function impairment with serum creatinine >2 mg/dL (unless attributable to ALL)
  • Severe neuropsychiatric disorder that impairs the patient's ability to understand and sign the informed consent, or to cope with the intended treatment plan
  • Presence of serious, active, uncontrolled infections
  • Pre-existing HIV positive serology (i.e. already known before enrolment). If HIV positivity is detected after enrolment, the patient is put off study.
  • Pregnancy
  • Men and women should use effective contraception during treatment and for at least 6 months after Asparaginase discontinuation. As a precautionary measure, breast-feeding should be discontinued during treatment with Asparaginase and should not be restarted after discontinuation of Asparaginase

研究组 & 干预措施

Patients on Oncospar

Experimental

干预措施: Asparaginase (Drug)

结局指标

主要结局

Number of patients with active serum Asparaginase

时间窗: After 8 months from study entry

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验

进行中(未招募)
1 期
The aim of the study is to monitor the activity of Asparaginase, an enzyme that acts by degrading asparagine, an important component of proteins without which cells can not survive.Normal cells can produce asparagine independently, while some cancer cells are unable to do so. Asparaginase reduces the level of asparagine in the blood cells and stops the growth of cancer cells.Adult patients, aged between 18 and 65, diagnosed with Acute Ph Lymphoblastic Leukemia negative (LAL Ph-) untreated, with a favorable impact on the prognosis.MedDRA version: 21.0Level: LLTClassification code 10060390Term: Leukaemia lymphoblastic acuteSystem Organ Class: 100000004864
EUCTR2018-003517-17-ITFONDAZIONE GIMEMA (GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL' ADULTO) FRANCO MANDELLI ONLUS52
已完成
4 期
Therapeutic drug monitoring of asparaginase and methotrexate metabolism in childhood acute lymphoblastic leukemia.Blood cancer10024324leukemia
NL-OMON44473Erasmus MC, Universitair Medisch Centrum Rotterdam70
已完成
不适用
TDM of Asparaginase in ALL2008Acute Lymphoblastic Leukemia
NCT04843514Aarhus University Hospital765
已完成
不适用
Pharmacokinetics of asparaginase in patients with acute lymphoblastic leukemia: prospective observational study.acute lymphoblastic leukemia (ALL)
JPRN-UMIN000040630Japan Children's Cancer Study Group(JCCG)110
已完成
不适用
Acyclovir Therapy for Genital Herpes Ulcers in HIV Negative African WomenUlcers of Female Genital Organs
NCT02053142University of North Carolina, Chapel Hill74